Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
June 14 2017 - 7:30AM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
members of its management team are scheduled to present at the JMP
Securities Life Sciences Conference at 3:00 PM ET on Tuesday, June
20, 2017 in New York City.
A live audio webcast of the Pacira presentation can
be accessed by visiting the “Investors & Media” section of the
company’s website at investor.pacira.com. A replay of the webcast
will be archived on the Pacira website for two weeks following the
presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a
specialty pharmaceutical company focused on the clinical and
commercial development of new products that meet the needs of acute
care practitioners and their patients. The company’s flagship
product, EXPAREL® (bupivacaine liposome injectable suspension),
indicated for single-dose infiltration into the surgical site to
produce postsurgical analgesia, was commercially launched in the
United States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Company Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco
(973) 451-4030
Susan.mesco@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024